2 recruiting. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow BNT324: new trials by email Literature Review of BNT324 trials Research Report on BNT324
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer BNT324, Docetaxel, Prednisone/prednisolone - Metastatic Castration-resistant Prostate Cancer | Phase 3 | Recruiting | BioNTech SE | 736 | 2026-04-22 | 2026-10-16 |
| A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer BNT324, BNT327 - Advanced Lung Cancer | Phase 1 / Phase 2 | Recruiting | BioNTech SE | 594 | 2025-05-02 | 2026-08-26 |
Carcinoma, Non-Small-Cell Lung (1) · Small Cell Lung Carcinoma (1)
BioNTech SE (2)
Australia (2) · China (2) · Poland (2) · United Kingdom (2) · United States (2) · Belgium (1) · France (1) · Germany (1) · Italy (1) · Spain (1) · Taiwan (1) · Turkey (Türkiye) (1)
2025 (1)